Blueprint Medicines Revenue

In the fiscal year ending March 31, 2025, Grasim Industries had annual revenue of 1.48T INR with 13.36% growth. Grasim Industries had revenue of 462.61B in the quarter ending March 31, 2025, with 22.62% growth.

Revenue

1,484.78B INR

Revenue Growth

+13.36%

P/S Ratio

1.16

Revenue / Employee

54.33M INR

Employees

27,327

Market Cap

18.61B USD

Revenue Chart

* This company reports financials in INR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1,484.78B	174.99B	13.36%
Mar 31, 2024	1,309.78B	133.51B	11.35%
Mar 31, 2023	1,176.27B	219.26B	22.91%
Mar 31, 2022	957.01B	192.97B	25.26%
Mar 31, 2021	764.04B	12.64B	1.68%
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Reinet Investments S.C.A.	798.00M
CPI FIM	167.35M
Luxempart	50.29M
Socfinasia	186.43M
Socfinaf	591.38M
Velcan Holdings	2.95M
GP Investments	-8.48M

Revenue Rankings